My research interests lie in the area of infectious disease clinical, laboratory, and translational research due to bacteria and fungus. My group is focused on understanding the mechanisms of resistance, pharmacokinetics, pharmacodynamics, and outcomes of antibacterial and antifungal pharmacotherapy. This is being accomplished by evaluating

• in vitro activity of antifungal and antimicrobial agents alone and in combination for the treatment of serious fungal infections, gram-positive pathogens and gram-negative pathogens   such as P. aeruginosa , Acinetobacter , and extended-spectrum beta-lactamase producing Klebsiella,
• pharmacokinetics and pharmacodynamics of antifungal and antimicrobials in vitro and in vivo,
• epidemiology of anti-infective resistance, anti-infective usage patterns and the relationships between resistance, anti-infective usage, and pharmacodynamics.
• outcomes of disease state management programs which we developed and implemented for infectious diseases.

Finally, we enjoy providing education and training to healthcare professionals and the general public about the appropriate and rational use of anti-infectives.